Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sakiko Inatsu"'
Publikováno v:
Japanese Journal of Food Microbiology. 39:29-32
Publikováno v:
Japanese Journal of Food Microbiology. 38:9-12
Publikováno v:
Japanese Journal of Food Microbiology. 35:149-153
Publikováno v:
Japanese Journal of Food Microbiology. 34:126-130
Autor:
Sakiko Inatsu, Fujihiko Matsunaga
Publikováno v:
Japanese Journal of Food Microbiology. 33:202-208
Autor:
Tomoaki Kouya, Mamoru Tanaka, Harumi Sato, Masayuki Taniguchi, Sakiko Inatsu, Kumiko Nagata, Yoshihiro Fukuda
Publikováno v:
Helicobacter. 15:422-429
Background: Triple therapy with amoxicillin, clarithromycin, and a proton-pump inhibitor is a common therapeutic strategy for the eradication of Helicobacter pylori (H. pylori). However, frequent appearance of clarithromycin-resistant strains is a th
Autor:
Naohiro Ishikawa, Tomoko Mizote, Sebastian Suerbaum, Sören Schreiber, Alexey Dudnik, Christine Josenhans, Sakiko Inatsu, Shin-Ichi Aizawa, Tobias Schweinitzer
Publikováno v:
Journal of Bacteriology. 190:3244-3255
Helicobacter pylori requires flagellar motility and chemotaxis to establish and maintain chronic infection of the human stomach. The pH gradient in the stomach mucus is essential for bacterial orientation and guides the bacterium toward a narrow laye
Autor:
Kazuhiko Nakajima, Yoshihiro Fukuda, Tomoko Mizote, Kazue Aoyama, Yoko Nagata, Kumiko Nagata, Sakiko Inatsu
Publikováno v:
Biomedical Research. 29:9-18
H. pylori is a gram-negative bacterium associated with gastric inflammation and peptic ulcer and considered a risk factor for gastric cancer in its natural habitat. However, the energy metabolism of H. pylori in the stomach remains to be clarified. H
Autor:
Kumiko, Nagata, Sakiko, Inatsu, Mamoru, Tanaka, Harumi, Sato, Tomoaki, Kouya, Masayuki, Taniguchi, Yoshihiro, Fukuda
Publikováno v:
Helicobacter. 15(5)
Triple therapy with amoxicillin, clarithromycin, and a proton-pump inhibitor is a common therapeutic strategy for the eradication of Helicobacter pylori (H. pylori). However, frequent appearance of clarithromycin-resistant strains is a therapeutic ch
Growth of Helicobacter pylori was inhibited by the quinones, idebenone, duroquinone, menadione, juglone, and coenzyme Q 1 at low concentrations of 0.8 to 3.2 μg/ml. Idebenone specifically inhibited H. pylori growth by inhibiting respiration and decr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f47c6a5316036be21074239abe605b
https://europepmc.org/articles/PMC1479114/
https://europepmc.org/articles/PMC1479114/